About
Cambridge Innovation Capital is a leading venture investor in the Cambridge ecosystem, focusing on life sciences and deep tech. They provide financial backing and expert guidance to entrepreneurs in knowledge-intensive businesses, leveraging their unique relationship with the University of Cambridge and deep network to identify and support promising start-ups. Their goal is to enable these pioneers to create world-leading companies with financial success and global impact.
Key facts
- Website
- cic.vc
- Headquarters
- United Kingdom
- Portfolio companies
- 9
- Stages
- Series A
- Cheque size
- $6M to $222M
Recent investments
| Date | Company | Round | Amount |
|---|---|---|---|
| 14 Oct 2026 | Salience Labs | Series B | $125M |
| 1 Oct 2026 | Microbiotica | Series C | $45M |
| 7 Apr 2026 | Trent AI | Seed | $13M |
| 17 May 2022 | Congenica | Undisclosed round | $50M |
| 1 Dec 2021 | Organox | Undisclosed round | $25M |
| 28 Jan 2020 | Congenica | Undisclosed round | $14M |
| 1 Sept 2016 | Organox | Undisclosed round | $10M |
| 1 Sept 2015 | Congenica | Undisclosed round | $8M |
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
What companies has Cambridge Innovation Capital invested in?
Cambridge Innovation Capital has invested in Salience Labs, Microbiotica, Trent AI, Congenica, Organox and 4 more.
SEC filings, insider activity, nonprofit links and pay benchmarks for Cambridge Innovation Capital:
